Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
West syndrome (WS) is a specific type of epilepsy (or seizure disorder) that has three
features: infantile spasms (type of seizure), loss of milestones, and a specific pattern on
electroencephalogram (EEG or brain wave test) called hypsarhythmia. The purpose of this study
is to detect pre-hypsarhythmia in infants at high-risk for WS and determine whether treatment
with ACTH will prevent WS.
Phase:
N/A
Details
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago